Smart syringe market seen topping $21.46 billion by 2030

The Business Research Company says the smart syringe market will grow from $12.15 billion in 2025 to $13.55 billion in 2026, then reach $21.46 billion by 2030. The forecast points to rising vaccination demand, chronic disease care, worker-safety rules and faster adoption of safety-engineered injection devices.

Why it matters: - Smart syringes are becoming a bigger part of infection control, medication safety and injection efficiency across healthcare systems. - The market outlook signals sustained demand for devices that can reduce needlestick injuries, medication errors and bloodborne pathogen exposure. - Growing healthcare spending is helping speed adoption of advanced medical devices that lower complication-related costs.

What happened: - The Business Research Company released a smart syringe market study on August 30, 2026. - The study puts the market at $12.15 billion in 2025 and $13.55 billion in 2026. - The report forecasts the market will reach $21.46 billion by 2030. - The 2026-2030 period implies a 12.2% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company offers a free sample of the report and a full report online: Download a free sample and View the full report.

The details: - The market grew on the back of global vaccination programs, more chronic illnesses, greater healthcare worker safety awareness, wider use of single-use injection devices and more hospital-based injection procedures. - Future growth is tied to demand for advanced drug administration devices, government mandates promoting safety syringes, home healthcare expansion, digital medication tracking and mass immunization campaigns. - Key trends include more use of auto-disable and safety-engineered syringes. - Other trends include dose accuracy monitoring, needlestick injury prevention, smart drug delivery technologies and stricter infection-control compliance. - Smart syringes combine technology with injection devices to improve safety, precision and efficiency. - The devices are designed to address needlestick injuries, medication errors and transmission of bloodborne pathogens. - Healthcare expenditure is rising worldwide because of aging populations, chronic disease growth, medical technology advances and higher patient expectations. - In November 2023, the Canadian Institute for Health Information projected Canada’s total health expenditure at $344 billion for 2023, up 2.8% from the prior year.

Between the lines: - The forecast suggests smart syringes are moving from a niche safety tool toward a broader standard for injection delivery. - Government mandates and digital tracking needs point to a market shaped by regulation as much as by product innovation. - Regional growth patterns suggest mature markets such as North America remain important, while Asia-Pacific may offer the fastest volume expansion. - The report’s added analytics, including market attractiveness scoring and TAM analysis, show that investors and suppliers are being pushed toward more granular planning.

What's next: - The market is expected to keep expanding through 2030 as healthcare systems adopt more safety-engineered and digitally connected injection tools. - Broader use in home care and immunization programs could widen the customer base beyond hospitals. - The company says the 2026 edition of its reports now includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated trend analysis. - The Business Research Company also lists contact details for expert inquiries and social channels, including LinkedIn, Facebook and X.